Trial intelligence / Profile preview

Pentamidine Secondary Prophylaxis for Visceral Leishmaniasis Relapses in HIV Co-infected Patients

NCT01360762Phase 3Completed

Sponsor
Institute of Tropical Medicine Antwerp
Start
Nov 2011
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of pentamidine in visceral leishmaniasis (VL), sponsored by Institute of Tropical Medicine Antwerp. Started Nov 2011; status: completed.

02

Drugs

pentamidine
03

Conditions

visceral leishmaniasis (VL)

Beyond the preview

Go deeper on NCT01360762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01360762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call